Zhang S, Zeng N, Wu S, Wu HH, Kong MW. Research progress in spasmodic torticollis rehabilitation treatment. World J Clin Cases 2024; 12(7): 1205-1214 [PMID: 38524504 DOI: 10.12998/wjcc.v12.i7.1205]
Corresponding Author of This Article
Mo-Wei Kong, MD, Doctor, Department of Cardiology, Guiqian International General Hospital, No. 1 Dongfeng Avenue, Guiyang 550018, Guizhou Province, China. 1600181272@qq.com
Research Domain of This Article
Rehabilitation
Article-Type of This Article
Minireviews
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. Mar 6, 2024; 12(7): 1205-1214 Published online Mar 6, 2024. doi: 10.12998/wjcc.v12.i7.1205
Research progress in spasmodic torticollis rehabilitation treatment
Shuang Zhang, Ni Zeng, Shuang Wu, Hui-Hui Wu, Mo-Wei Kong
Shuang Zhang, Ni Zeng, Shuang Wu, Hui-Hui Wu, Department of Rehabilitation, The Affiliated Hospital of Guizhou Medical University, Guiyang 550018, Guizhou Province, China
Mo-Wei Kong, Department of Cardiology, Guiqian International General Hospital, Guiyang 550018, Guizhou Province, China
Author contributions: Zhang S wrote the manuscript; Kong MW provided crucial suggestions and guidance for the writing; Wu S, Zeng N and Wu HH reviewed and revised the manuscript; all authors read and approved the final manuscript.
Conflict-of-interest statement: All the authors declare that they have no competing interests.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Mo-Wei Kong, MD, Doctor, Department of Cardiology, Guiqian International General Hospital, No. 1 Dongfeng Avenue, Guiyang 550018, Guizhou Province, China. 1600181272@qq.com
Received: October 21, 2023 Peer-review started: October 21, 2023 First decision: December 28, 2023 Revised: December 31, 2023 Accepted: February 6, 2024 Article in press: February 6, 2024 Published online: March 6, 2024
Abstract
Spasmodic torticollis (ST) is a focal dystonia that affects adults, causing limited muscle control and impacting daily activities and quality of life. The etiology and curative methods for ST remain unclear. Botulinum toxin is widely used as a first-line treatment, but long-term usage can result in reduced tolerance and adverse effects. Rehabilitation therapy, with its minimal side effects and low potential for harm, holds significant clinical value. This article explores the effectiveness of adjunctive therapies, including exercise therapy, transcranial magnetic stimulation, shockwave therapy, neuromuscular electrical stimulation, vibration therapy, electromyographic biofeedback, and acupuncture, in the treatment of ST. The aim is to provide clinicians with additional treatment options and to discuss the efficacy of rehabilitation therapy for ST.
Core Tip: Spasmodic torticollis (ST) is a focal dystonia characterized by involuntary contractions of the neck muscles, significantly impacting daily activities and quality of life. Botulinum toxin is a widely used first-line treatment for ST, but long-term use can lead to reduced efficacy and potential side effects. Surgical interventions may have associated complications. Rehabilitation therapy, including exercise therapy, has potential clinical value as a low-risk treatment option. It can be used as an adjunctive therapy for ST, showing efficacy in improving clinical outcomes and reducing tolerance to botulinum toxin.
